Onderneming Isodiol International Inc Canadian Securities Exchange
Aandelen
CA46500L1013
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
Nutritional Health Products
100,0
%
| 19 | 100,0 % | 22 | 100,0 % | +16,26% |
Verkoop per regio
CAD in miljoen | 2018 | Gewicht | 2019 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 19 | 100,0 % | 22 | 100,0 % | +16,26% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14-02-19 |
Dianne Szigety
SEC | Corporate Secretary | 69 | 01-03-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Director/Board Member | - | 21-11-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 98 334 359 | 98 334 359 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
![Adres Isodiol International Inc](https://cdn.zonebourse.com/static/address/35787115.png)
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,29% | 5,56 mld. | |
-33,07% | 3,55 mld. | |
-3,24% | 3,01 mld. | |
-24,56% | 2,64 mld. | |
-10,17% | 2,3 mld. | |
+46,81% | 1,95 mld. | |
+48,03% | 1,52 mld. | |
-11,69% | 1,45 mld. | |
+43,81% | 1,38 mld. |